Medical and Pharmaceutical Nuvation Bio scoops US$250M financing to launch promising lung cancer therapeutic Taletrectinib is the most advanced drug in the company's pipeline Rowan DunneMarch 4, 2025
Medical and Pharmaceutical Early lung cancer diagnosis saves 52-year-old Indian man’s life A persistent cough and breathlessness while climbing stairs prompted him to visit the hospital Rowan DunneFebruary 13, 2025
Medical and Pharmaceutical Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds The investigators examined data from more than 7,000 patients over an 11-year period to make this determination Rowan DunneJanuary 30, 2025
Medical and Pharmaceutical South Korean researchers come up with novel treatment option for lung cancer Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases Joseph MortonJanuary 16, 2025
Medical and Pharmaceutical Scientists develop scan technique to light up aggressive lung cancer ‘like a Christmas tree’ More treatment innovation just in time for the holidays Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024
Medical and Pharmaceutical GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most The first patient has been screened with the R&D-stage test in a Phase III study Rowan DunneNovember 19, 2024
Medical and Pharmaceutical Novocure scoops FDA approval for electric field lung cancer treatment device The Swiss oncology company's stock rose by over 33% as a result Rowan DunneOctober 16, 2024